Mark L Brantly
11PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Sep 29, 2025
Pioglitazone reduces hepatic α-1 antitrypsin accumulation through autophagy and AMPK activation in α-1 antitrypsin-deficient mice.Yuanqing Lu, Regina Oshins, Nesmine R Maptue
|Jan 15, 2025
Inhaled alpha-1 antitrypsin (AAT) restores lower respiratory tract protease-antiprotease homoeostasis and reduces inflammation in AAT-deficient individuals: a randomised phase 2 study.Mark Brantly, James Stocks, Jorge Lascano
|Sep 19, 2024
Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model.Yuanqing Lu, Naweed S Mohammad, Jungnam Lee
|Feb 28, 2024
Monocyte NLRP3 inflammasome and interleukin-1β activation modulated by alpha-1 antitrypsin therapy in deficient individuals.Debananda Gogoi, Howard Yu, Michelle Casey
|Sep 20, 2023
Development of a risk score to increase detection of severe alpha-1 antitrypsin deficiency.E Leonard Riley, J Cory Brunson, Soroush Eydgahi
|Sep 19, 2023
Treatment for Alpha-1 Antitrypsin Deficiency: Does Augmentation Therapy Work?Mark Brantly
Pageof 2
Frequent Collaborators
4 joint publications
Nazli Khodayari
1 joint publications
Alek M Aranyos
1 joint publications
Rodolfo Alvarado
1 joint publications
Alberto Riva
1 joint publications
Chalermchai Khemtong
1 joint publications
Kenneth Cusi
1 joint publications
E Leonard Riley
1 joint publications
Emer P Reeves
1 joint publications
Yuanqing Lu
